The effect of inhaled nitric oxide on shunt fraction in mechanically ventilated patients with COVID‑19 pneumonia
Article Sidebar
Main Article Content
Abstract
Studies in patients with severe acute respiratory distress syndrome (ARDS) with refractory hypoxaemia suggest that inhaled nitric oxide (iNO) can be added to ventilatory strategies as a potential bridge to clinical improvement. However, the potential role of iNO as a management strategy in severe COVID-19 pneumonia remains unclear. The authors describe their clinical findings of using iNO for severe COVID-19 pneumonia in 10 patients with refractory hypoxaemia in a tertiary respiratory intensive care unit. The results showed an improvement in shunt fraction, P/F ratio, PaO2 and arterial oxygen saturation but the improvements did not translate into a mortality benefit. This report adds to the current body of literature indicating that the correct indications, timing, dose and duration of iNO therapy and how to harness its pleiotropic effects still remain to be elucidated.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
How to Cite
References
Parker A, Karamchand S, Schrueder N, et al. Leadership and early strategic response to the SARS-CoV-2 pandemic at a COVID‑19 designated hospital in South Africa. S Afr Med J 2020;110(6):463-465. https://doi.org/10.7196/SAMJ.2020v110i6.14809
Gebistorf F, Karam O, Wetterslev J, Afshari A. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults. Cochrane Database Syst Rev 2016, Issue 6. Art. No.: CD002787. https://doi.org/10.1002/14651858.CD002787.pub3
Griffiths MJD, McAuley DF, Perkins GD, et al. Guidelines on the management of acute respiratory distress syndrome. BMJ Open Respir Res 2019;6(1):e000420. https://doi.org/10.1136/bmjresp-2019-000420
Kobayashi J. Effects of inhaled nitric oxide in COVID‑19-induced ARDS – is it worthwhile? Acta Anaesthesiol Scand 2021;65(10):1522-1523. https://doi.org/10.1111/aas.13961
Kamenshchikov NO, Berra L, Carroll RW. Therapeutic effects of inhaled nitric oxide therapy in COVID‑19 patients. Biomedicines 2022;10(2):369. https://doi.org/10.3390/biomedicines10020369
Ghosh A, Joseph B, Anil S. Nitric oxide in the management of respiratory consequences in COVID‑19: A scoping review of a different treatment approach. Cureus 2022;14(4):e23852. https://doi.org/10.7759/cureus.23852
Berggren SM. The oxygen deficit of arterial blood caused by non-ventilating parts of the lung. Acta Physiol Scand 1942;11(4):Suppl 11.
Manktelow C, Bigatello LM, Hess D, Hurford WE. Physiologic determinants of the response to inhaled nitric oxide in patients with acute respiratory distress syndrome. wAnesthesiology 1997;87(2):297-307. https://doi.org/10.1097/00000542-199708000-00017
Ferrari M, Santini A, Protti A, et al. Inhaled nitric oxide in mechanically ventilated patients with COVID‑19. J Crit Care 2020;60:159-160. https://doi.org/10.1016/j.jcrc.2020.08.007
Lotz C, Muellenbach RM, Meybohm P, et al. Effects of inhaled nitric oxide in COVID‑19-induced ARDS – is it worthwhile? Acta Anaesthesiol Scand 2021;65(5):629-632. https://doi.org/10.1111/aas.13757
Gutierrez G. Central and mixed venous O2 saturation. Turk J Anaesthesiol Reanim 2020;48(1):2-10. https://doi.org/10.5152/TJAR.2019.140
Walley KR. Use of central venous oxygen saturation to guide therapy. Am J Respir Crit Care Med 2012;184(5):514-520. https://doi.org/101164/rccm201010-1584CI